BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32676335)

  • 1. PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC).
    Sun L; Han T; Zhang X; Liu X; Li P; Shao M; Dong S; Li W
    Transl Lung Cancer Res; 2020 Jun; 9(3):731-744. PubMed ID: 32676335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
    Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
    Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling.
    Du B; Cawthorn WP; Su A; Doucette CR; Yao Y; Hemati N; Kampert S; McCoin C; Broome DT; Rosen CJ; Yang G; MacDougald OA
    J Biol Chem; 2013 Feb; 288(5):3036-47. PubMed ID: 23250756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.
    Du W; Liu X; Yang M; Wang W; Sun J
    Onco Targets Ther; 2021; 14():4223-4229. PubMed ID: 34295164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness
    Liu X; Wang Z; Yang Q; Hu X; Fu Q; Zhang X; Li W
    Front Oncol; 2022; 12():858694. PubMed ID: 35530319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stemness is Derived from Thyroid Cancer Cells.
    Ma R; Bonnefond S; Morshed SA; Latif R; Davies TF
    Front Endocrinol (Lausanne); 2014; 5():114. PubMed ID: 25076938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.
    Chen Z; Chen Y; Li Y; Lian W; Zheng K; Zhang Y; Zhang Y; Lin C; Liu C; Sun F; Sun X; Wang J; Zhao L; Ke Y
    Cell Death Dis; 2021 Jun; 12(6):615. PubMed ID: 34131109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of T-Box Transcription Factor
    Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evodiamine exerts inhibitory roles in non‑small cell lung cancer cell A549 and its sub‑population of stem‑like cells.
    Lu X; Zhang W; Liu Y; Liu M
    Exp Ther Med; 2022 Dec; 24(6):746. PubMed ID: 36561974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.
    Zakaria N; Mohd Yusoff N; Zakaria Z; Widera D; Yahaya BH
    Front Oncol; 2018; 8():166. PubMed ID: 29868483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway.
    Guo J; Guo M; Zheng J
    Cancer Manag Res; 2021; 13():773-785. PubMed ID: 33536785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.